SOURCE: SpectraScience, Inc.

SpectraScience, Inc.

September 06, 2012 09:00 ET

SpectraScience to Present at the Rodman & Renshaw Global Investment Conference on September 11th

SAN DIEGO, CA--(Marketwire - Sep 6, 2012) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 11, at 10:25 a.m. Eastern. The conference is being held at Waldorf Astoria Hotel in New York City. 

A webcast of the Company's presentation can be found at:

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

Contact Information

  • Contact:
    SpectraScience, Inc.
    Jim Dorst
    Chief Financial Officer
    (858) 405-9933

    Investor Relations
    Don Markley
    Email Contact
    (310) 691-7100